StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MAIA Biotechnology's enterprise value was $62.64M on Nov 11, 2026, against $40.65M a year earlier. Over the last 4 years it ranged from $7.66M to $89.49M, with a median of $46.45M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$62.64M+18.8%
2025Dec 31, 2025$52.71M+11.1%
2024Dec 31, 2024$47.45M+374.7%
2023Dec 29, 2023$10.00M-59.0%
2022Dec 30, 2022$24.36M–

More MAIA Biotechnology figures

See a number that looks wrong?